- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Case Reports in Medicine
Volume 2010 (2010), Article ID 982521, 4 pages
Pneumococcal Tricuspid Valve Endocarditis in a Young African American: A Case for Inclusion of African Americans in Pneumococcal Vaccine Criteria
1Department of Internal Medicine, Meharry Medical College, 1005 Dr. D.B. Todd Jr. Boulevard, Nashville, TN 37208, USA
2Department of Internal Medicine, Aultman Hospital, 2600 6th st SW, Canton, OH 44710, USA
3Department of Cardiology, Meharry Medical College, 1005 Dr. D.B. Todd Jr. Boulevard, Nashville, TN 37208, USA
Received 22 June 2010; Accepted 23 August 2010
Academic Editor: Grigorios Korosoglou
Copyright © 2010 Oghenerukevwe Odiete et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- R. Nandakumar and G. Raju, “Isolated tricuspid valve endocarditis in nonaddicted patients: a diagnostic challenge,” American Journal of the Medical Sciences, vol. 314, no. 3, pp. 207–212, 1997.
- V. Ugolini, A. Pacifico, T. C. Smitherman, and P. A. Mackowiak, “Pneumococcal endocarditis update: analysis of 10 cases diagnosed between 1974 and 1984,” American Heart Journal, vol. 112, no. 4, pp. 813–819, 1986.
- J. P. Nuorti, J. C. Butler, M. M. Farley et al., “Cigarette smoking and invasive pneumococcal disease,” The New England Journal of Medicine, vol. 342, no. 10, pp. 681–689, 2000.
- C. A. Lexau, R. Lynfield, R. Danila et al., “Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine,” Journal of the American Medical Association, vol. 294, no. 16, pp. 2043–2051, 2005.
- P. Pastor, F. Medley, and T. V. Murphy, “Invasive pneumococcal disease in Dallas County, Texas: results from population-based surveillance in 1995,” Clinical Infectious Diseases, vol. 26, no. 3, pp. 590–595, 1998.
- Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs) Report. Emerging Infections Program Network, “Streptococcus pneumoniae 1999,” http://www.cdc.gov/abcs/reports-findings/survreports/spneu99.html.
- D. Greenberg, N. Givon-Lavi, A. Broides, I. Blancovich, N. Peled, and R. Dagan, “The contribution of smoking and exposure to tobacco smoke to Streptococcus pneumoniae and Haemophilus influenzae carriage in children and their mothers,” Clinical Infectious Diseases, vol. 42, no. 7, pp. 897–903, 2006.
- J. F. Varona and J. M. Guerra, “Tricuspid valve endocarditis in a nonaddicted patient without predisposing myocardiopathy,” Revista Espanola de Cardiologia, vol. 57, no. 10, pp. 993–996, 2004.
- D. P. Naidoo, “Right-sided endocarditis in the non-drug addict,” Postgraduate Medical Journal, vol. 69, no. 814, pp. 615–620, 1993.
- P. Chan, J. D. Ogilby, and B. Segal, “Tricuspid valve endocarditis,” American Heart Journal, vol. 117, no. 5, pp. 1140–1146, 1989.
- S. I. Aronin, S. K. Mukherjee, J. C. West, and E. L. Cooney, “Review of pneumococcal endocarditis in adults in the penicillin era,” Clinical Infectious Diseases, vol. 26, no. 1, pp. 165–171, 1998.
- J. E. Bothwell, F. Casey, and C. H. Webb, “Tricuspid valvar endocarditis caused by penicillin resistant pneumococcus,” Cardiology in the Young, vol. 11, no. 5, pp. 556–558, 2001.
- M. Siegel and J. Timpone, “Penicillin-resistant Streptococcus pneumoniae endocarditis: a case report and review,” Clinical Infectious Diseases, vol. 32, no. 6, pp. 972–974, 2001.
- L. J. McKibben, P. V. Stange, V. P. Sneller, R. A. Strikas, and L. E. Rodewald, “Use of standing orders programs to increase adult vaccination rates: recommendations of the Advisory Committee on Immunological Practices,” MMWR: Morbidity and Mortality Weekly Report, vol. 49, no. 1, pp. 15–16, 2000.
- K. A. Robinson, W. Baughman, G. Rothrock et al., “Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995–1998 opportunities for prevention in the conjugate vaccine era,” Journal of the American Medical Association, vol. 285, no. 13, pp. 1729–1735, 2001.
- W. C. Albrich, W. Baughman, B. Schmotzer, and M. M. Farley, “Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine,” Clinical Infectious Diseases, vol. 44, no. 12, pp. 1569–1576, 2007.